March 21, 2024, Seattle - Circling in on Evaporation: Dry Eye Disease Case Discussions

Seattle, WA US
March 21, 2024

Thursday, March 21, 2024
6:00 PM – 6:30 PM PT Attendee Check-In
6:30 PM – 8:30 PM PT CE Dinner Meeting

Ruth's Chris Steak House Seattle

727 Pine Street
Seattle, Washington

Target Audience

This educational activity is intended for optometrists.

Learning Objectives

After completing this activity, participants will be better able to:

  • Review the function of the tear film in maintaining a healthy ocular surface
  • Use diagnostic strategies to identify dry eye disease
  • Identify treatments for a variety of patients with dry eye disease according to clinical evidence
Course summary
Available credit: 
  • 2.00 COPE
Course opens: 
Course expires: 
Event starts: 
03/21/2024 - 9:30pm EDT
Event ends: 
03/21/2024 - 11:30pm EDT
Ruth's Chris Steak House Seattle
727 Pine Street
Seattle, WA 98101
United States
+1 (206) 624-8524


Melissa Barnett, OD, FAAO, FSLS, FBCLA
Director of Optometry
University of California, Davis
Davis, California

Series Co-Chairs

Melissa Barnett, OD, FAAO, FSLS, FBCLA
Director of Optometry
University of California, Davis
Davis, California

Walter O. Whitley, OD, MBA, FAAO
Director, Optometric Services
Virginia Eye Consultants
Virginia Beach, Virginia

Disclosure Policy

MedEdicus requires that anyone who is in a position to control the content of this educational activity disclose all relevant financial relationships with any commercial interest. Financial relationship information is collected and resolved prior to the educational activity. All relevant relationships have been mitigated.


Melissa Barnett, OD, is a consultant for CooperVision and Visus Therapeutics; is an advisory board member of ABB, AbbVie Inc, AccuLens, Azura Ophthalmics Ltd, Bausch & Lomb Incorporated, Bruder Healthcare, CooperVision, Dompé US, Inc, EveryDay Contacts, Johnson & Johnson Vision Care, Inc, Lenstechs, Mojo Vision Inc*, Novartis Pharmaceuticals Corporation, OCuSOFT Inc, Orasis Pharmaceuticals, Oyster Point Pharma, Inc, Percept Technologies Inc, RVL Pharmaceuticals, Scleral Lens Education Society, ScienceBased Health, Sight Sciences, Sjögren’s Syndrome Foundation, Sun Pharmaceutical Industries, Inc, Tarsus Pharmaceuticals, Inc, Vistakon, Visus Therapeutics, and Vyluma; and is on the speakers bureau for British Contact Lens Association, CooperVision, Gas Permeable Lens Institute, Oyster Point Pharma, Inc, RVL Pharmaceuticals, ScienceBased Health, Scleral Lens Education Society, Sjögren’s Syndrome Foundation, STAPLE Program, and Tarsus Pharmaceuticals, Inc.

Walter O. Whitley, OD, MBA, is a consultant for AbbVie Inc, Alcon, Aldeyra Therapeutics, Apellis Pharmaceuticals, Astellas Pharma Inc, Bruder Healthcare, Dompé US, Inc, Eyenovia, Inc, Heru, Inc, Mediprint, Novartis Pharmaceuticals Corporation, Oyster Point Pharma, Inc, Regener-Eyes, Tarsus Pharmaceuticals, Inc, and Thea Pharmaceuticals Limited; is an advisory board member of AbbVie Inc, Alcon, Bausch & Lomb Incorporated, Bruder Healthcare, Oyster Point Pharma, Inc, ScienceBased Health, Tarsus Pharmaceuticals, Inc, and Visus Therapeutics; is on the speakers bureau for AbbVie Inc, Alcon, Bausch & Lomb Incorporated, Oyster Point Pharma, Inc, and Sun Pharmaceutical Industries, Inc; and is a contracted researcher for Heru, Inc.

Planners, Managers, and Writers

MedEdicus planners and managers have no relevant commercial relationships to disclose.

* The financial relationship existed during the past 24 months but has now ended

Accreditation Statement

 COPE approved for 2.0 CE credits for optometrists.
COPE Course ID: 89099-TD (Synchronous In Person)
COPE Course Category: Treatment/Management of Ocular Disease


This activity, COPE Activity Number 127892, is accredited by COPE for continuing education for optometrists.

Disclosure of Commercial Support

MedEdicus LLC has received commercial support from Bausch & Lomb Incorporated for this activity in the form of an unrestricted educational grant.

The content of this COPE-Accredited CE activity was planned and prepared independently by MedEdicus LLC without input from members of an ineligible company.

Off-Label Discussion

This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.

Provider Contact Information

For questions about this educational activity, please contact MedEdicus LLC at


The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of State University of New York College of Optometry, MedEdicus LLC, or Bausch & Lomb Incorporated.

This CE activity is copyrighted to MedEdicus LLC ©2024. All rights reserved. MedEdicus does not claim copyright to material included herein owned by third parties for which attribution or citation has been made. 312

Available Credit

  • 2.00 COPE
Please login or register to take this course.

Please login if you already have an account on the MedEdicus Learning Portal OR Register to create an account and sign up for this dinner meeting.

We look forward to seeing you in Seattle on March 21!

If you do not receive an email confirmation, please check your spam folder or email